Investors have their eyes set on these three stocks with buy rank and robust momentum characteristics for January 2nd.
BrainsWay Ltd. (BWAY)
Manufacturing non-invasive neurostimulation treatments for mental health disorders, BrainsWay carries a Zacks Rank #1 and has seen the Zacks Consensus Estimate for its current year earnings surge by 38.9% over the previous 60 days.
BrainsWay Ltd. Sponsored ADR Price and Consensus
BrainsWay’s shares have demonstrated stellar performance, gaining 66.5% over the last three months compared with the S&P 500’s advance of 12.2%. The company possesses a Momentum Score of A.
Ryanair Holdings plc (RYAAY)
This passenger airline company holds a Zacks Rank #1 and has witnessed the Zacks Consensus Estimate for its current year earnings increase by 5.3% over the last 60 days.
Ryanair Holdings PLC Price and Consensus
Ryanair’s shares have surged by 38.9% over the last three months compared with the S&P 500’s advance of 12.2%. The company possesses a Momentum Score of A.
Equinox Gold Corp. (EQX)
Engaged in the exploration and development of mineral properties, Equinox Gold has a Zacks Rank #1 and has witnessed the Zacks Consensus Estimate for its current year earnings skyrocket by 72.7% over the last 60 days.
Equinox Gold Corp. Price and Consensus
Equinox’s shares have shown significant growth, gaining 15.6% over the last three months compared with the S&P 500’s advance of 12.2%. The company possesses a Momentum Score of A.
Give the full list of top ranked stocks here a look for more opportunities.
Explore more about the Momentum score and how it is calculated here.
Hoping to see these just-released stocks with enormous potential? Check out the new top 10 stocks for 2024.
Ready to download the 7 best stocks for the next 30 days recommended by Zacks Investment Research?
For further insights, refer to the comprehensive reports on each of these stocks: Ryanair Holdings PLC (RYAAY), BrainsWay Ltd. Sponsored ADR (BWAY), and Equinox Gold Corp. (EQX).
For more financial news, visit Zacks Investment Research.
